Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 12
Results: 21
Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8<sup>+</sup> T‑cells from GzmB mediated self‑destruction.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3071, doi. 10.1007/s00262-022-03224-2
- By:
- Publication type:
- Article
Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8<sup>+</sup> T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3057, doi. 10.1007/s00262-022-03223-3
- By:
- Publication type:
- Article
High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3013, doi. 10.1007/s00262-022-03222-4
- By:
- Publication type:
- Article
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3029, doi. 10.1007/s00262-022-03220-6
- By:
- Publication type:
- Article
Functional expression of CD73 on human natural killer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3043, doi. 10.1007/s00262-022-03219-z
- By:
- Publication type:
- Article
Natural killer cells and acute myeloid leukemia: promises and challenges.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2849, doi. 10.1007/s00262-022-03217-1
- By:
- Publication type:
- Article
Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3099, doi. 10.1007/s00262-022-03216-2
- By:
- Publication type:
- Article
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2999, doi. 10.1007/s00262-022-03213-5
- By:
- Publication type:
- Article
Targeting tumor extracellular matrix activates the tumor-draining lymph nodes.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2957, doi. 10.1007/s00262-022-03212-6
- By:
- Publication type:
- Article
Checkpoint-inhibitor induced Polyserositis with Edema.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3087, doi. 10.1007/s00262-022-03211-7
- By:
- Publication type:
- Article
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2943, doi. 10.1007/s00262-022-03210-8
- By:
- Publication type:
- Article
In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4<sup>+</sup> and CD8<sup>+</sup> T-cell epitopes for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2969, doi. 10.1007/s00262-022-03209-1
- By:
- Publication type:
- Article
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 3093, doi. 10.1007/s00262-022-03208-2
- By:
- Publication type:
- Article
Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2869, doi. 10.1007/s00262-022-03205-5
- By:
- Publication type:
- Article
Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2837, doi. 10.1007/s00262-022-03203-7
- By:
- Publication type:
- Article
First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2913, doi. 10.1007/s00262-022-03202-8
- By:
- Publication type:
- Article
Tcf-1 protects anti-tumor TCR-engineered CD8<sup>+</sup> T-cells from GzmB mediated self-destruction.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2881, doi. 10.1007/s00262-022-03197-2
- By:
- Publication type:
- Article
Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2929, doi. 10.1007/s00262-022-03192-7
- By:
- Publication type:
- Article
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2985, doi. 10.1007/s00262-022-03191-8
- By:
- Publication type:
- Article
Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2901, doi. 10.1007/s00262-022-03189-2
- By:
- Publication type:
- Article